| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.8 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |